Drug Shortage Report for FRAXIPARINE FORTE
| Report ID | 127472 |
| Drug Identification Number | 02240114 |
| Brand name | FRAXIPARINE FORTE |
| Common or Proper name | Fraxiparine® Forte (nadroparin calcium injection (1.0 mL)) |
| Company Name | ASPEN PHARMACARE CANADA INC. |
| Market Status | DORMANT |
| Active Ingredient(s) | NADROPARIN CALCIUM |
| Strength(s) | 19000UNIT |
| Dosage form(s) | SOLUTION |
| Route of administration | INTRAVENOUS SUBCUTANEOUS INTRAVENOUS SUBCUTANEOUS |
| Packaging size | 10 PF Syringe |
| ATC code | B01AB |
| ATC description | ANTITHROMBOTIC AGENTS |
| Reason for shortage | Other (Please describe in comments) |
| Anticipated start date | |
| Actual start date | 2020-10-29 |
| Estimated end date | Unknown |
| Actual end date | |
| Shortage status | Actual shortage |
| Updated date | 2020-10-30 |
| Company comments | n/a |
| Health Canada comments | |
| Tier 3 Status | No |
| Contact Address | 2030 BRISTOL CIRCLE, SUITE 201 OAKVILLE, ONTARIO CANADA L6H 0H2 |
| Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v3 | 2020-10-30 | English | Compare |
| v2 | 2020-10-29 | French | Compare |
| v1 | 2020-10-29 | English | Compare |
Showing 1 to 3 of 3